Latest News from: University Hospitals Cleveland Medical Center

Filters close
Released: 19-Dec-2016 2:05 PM EST
Pioneer in Corneal Surgery Receives Cornea Society’s Highest Honor
University Hospitals Cleveland Medical Center

Jonathan Lass, MD, has been awarded the Castroviejo Medal, the Cornea Society's highest honor. Dr. Lass, an ophthalmologist at University Hospitals Eye Institute at UH Cleveland Medical Center and Charles I Thomas Professor of Ophthalmology at Case Western Reserve University School of Medicine received the award in recognition of his lifetime contributions to research and advancements in corneal transplant and surgery.

Released: 19-Dec-2016 9:05 AM EST
UH Cleveland Medical Center Expanding Aortic Valve Replacement Procedure to Low-Risk Patients
University Hospitals Cleveland Medical Center

Announcement of a new clinical trial designed to measure the impact of transcatheter aortic valve replacement (TAVR) in low surgical risk patients with severe aortic stenosis (AS).

Released: 9-Dec-2016 9:45 AM EST
UH Seidman Cancer Center Expert Presents Novel Triple-Negative Breast Cancer Immunotherapy Trial at 2016 San Antonio Breast Cancer Symposium
University Hospitals Cleveland Medical Center

Joseph Baar, MD, PhD, Director of Breast Cancer Research at UH Seidman Cancer Center and Associate Professor at Case Western Reserve University School of Medicine, shared details about a phase II clinical trial testing the effectiveness of combining the chemotherapy drugs carboplatin and nab-paclitaxel with an immunotherapeutic agent called pembrolizumab (Keytruda) for use in patients with metastatic triple-negative breast cancer. Dr. Baar’s poster presentation was part of the Ongoing Trials-Targeted Therapy session on Dec. 8, 2016.

5-Dec-2016 8:45 PM EST
Advances in Multiple Myeloma, Lymphoma and Other Hematologic Malignancies Presented at Annual Meeting of American Society of Hematology
University Hospitals Cleveland Medical Center

News release about significant new research findings in multiple myeloma, lymphoma and other hematologic disorders presented by researchers from University Hospitals Seidman Cancer Center and Case Western Reserve University School of Medicine at the 58th Annual Meeting of American Society of Hematology (ASH) in San Diego.

2-Dec-2016 5:30 PM EST
Rainbow Babies & Children’s Experts to Present Pediatric Focused Data at 58th American Society of Hematology Annual Meeting
University Hospitals Cleveland Medical Center

Ashish Gupta, MBBS, MPH, a pediatric hematology fellow, will share results from one of the largest quality controlled retrospective studies of children with acquired aplastic anemia. The data makes a compelling case for the pediatric hematology community to revisit the current treatment algorithm for this rare disease.

Released: 3-Oct-2016 9:05 AM EDT
Study Reports Innovative Combination of Minimally Invasive Procedures Laser Interstitial Thermotherapy (LITT) & ‘Mini’ Craniotomy for Treating ‘Inoperable’ Brain Tumors
University Hospitals Cleveland Medical Center

A new paper in the October issue of the journal Neurosurgical Focus finds the use of laser beneficial for the removal of large, “inoperable” glioblastoma (GBM) and other types of brain tumors. The authors describe how they treated larger, inoperable tumors safely with LITT when combined with a very small craniotomy which allowed them to suck out the cooked tumor to prevent swelling.

Released: 14-Sep-2016 10:05 AM EDT
New Paper From University Hospitals Seidman Cancer Center Provides Insights for Music Therapy in Surgical Area
University Hospitals Cleveland Medical Center

A new paper describes how music therapists and perioperative nurses worked together to establish a music therapy program during a two-year clinical study looking at the effects of live and recorded music on the anxiety levels of patients undergoing breast biopsies.

Released: 2-Sep-2016 3:05 PM EDT
Researchers Find Gene Mutations Lead to More Aggressive Colorectal Cancer in African American Patients
University Hospitals Cleveland Medical Center

Case Comprehensive Cancer Center researchers, a collaboration which includes University Hospitals Seidman Cancer Center and Case Western Reserve University, who last year identified new gene mutations unique to colon cancers in African Americans, found that tumors with these mutations are highly aggressive and more likely to recur and metastasize.

Released: 1-Aug-2016 1:05 PM EDT
UH Case Medical Center Treats First Patient in the World on International Clinical Trial for Hypertension
University Hospitals Cleveland Medical Center

University Hospitals Case Medical Center is the first site in the world to perform a procedure on a patient in RADIANCE-HTN, an international clinical trial evaluating the effect of the ReCor Paradise® Renal Denervation System on lowering blood pressure with hypertension. The system uses ultrasound energy to treat overactive nerves leading to the kidney.RADIANCE-HTN is a blinded, randomized, sham-controlled trial.

Released: 27-Jul-2016 9:05 AM EDT
First Cancer Patient in Ohio Receives Proton Therapy Treatment
University Hospitals Cleveland Medical Center

University Hospitals in Cleveland treated its first patient using the MEVION S250 proton therapy system. The proton therapy treatment was the first in the State of Ohio.

Released: 18-Jul-2016 11:05 AM EDT
University Hospitals Neurological Institute Studies New Models for Understanding the Impact of Alzheimer’s Disease Using Functional Magnetic Resonance Imaging
University Hospitals Cleveland Medical Center

A new study hopes to develop a faster, more precise and more efficient real-time method for fMRI measurements in patients with Alzheimer’s disease.

Released: 8-Jul-2016 4:05 PM EDT
University Hospitals Case Medical Center Cardiologists First to Implant Abbott ‘Absorb’ Stent in Midwest
University Hospitals Cleveland Medical Center

University Hospitals Case Medical Center is among the first in the country – and the first in Ohio - to offer and deploy the Abbott Absorb stent, a completely bioresorbable stent. On July 8, University Hospitals (UH) implanted its first Absorb dissolving stent on a patient with coronary artery disease.

Released: 27-Jun-2016 3:05 PM EDT
Many Women with Early Stage Breast Cancer Experience Functional Decline After Initiating Treatment
University Hospitals Cleveland Medical Center

In a study of older women with newly diagnosed stage I to III breast cancer, approximately one in five lost the ability to complete some of the basic tasks necessary for independent living within one year of initiating treatment. Within 12 months, 34 of the 184 patients developed functional decline and seven died.

Released: 26-May-2016 1:05 PM EDT
University Hospitals Case Medical Center Neurosurgeon Studying if Deep Brain Stimulation Can Help Bipolar Disorder Sufferers
University Hospitals Cleveland Medical Center

A neurosurgeon who specializes in deep brain stimulation (DBS) is seeking a target in the brains of bi-polar disorder patients for possible DBS implantation to provide help to them.

Released: 19-May-2016 11:05 AM EDT
Robyn H. Strosaker, MD, Named VP & Chief Medical Officer at University Hospitals Case Medical Center
University Hospitals Cleveland Medical Center

Announcement of the appointment of a new vice president and chief medical officer at University Hospitals Case Medical Center in Cleveland, Ohio. The medical center is at the core of University Hospitals' $4 billion health system and is ranked among America’s best hospitals by U.S. News & World Report.

Released: 27-Apr-2016 4:05 PM EDT
UH Seidman Cancer Center First in the World to Apply SBRT to Partial Prostate Gland for Prostate Cancer
University Hospitals Cleveland Medical Center

University Hospitals Seidman Cancer Center physicians have started the world’s first clinical trial using a new form of stereotactic body radiotherapy (SBRT) to deliver radiation to a specific area of the prostate invaded with cancer – instead of the entire gland.

Released: 15-Dec-2015 3:05 PM EST
Study Finds that Eliminating Cost for Colorectal Cancer Screening Doesn’t Improve Screening Rates
University Hospitals Cleveland Medical Center

Making colonoscopy available at no cost to eligible Medicare beneficiaries under the Affordable Care Act (ACA) did not increase the number of people in this target population who regularly undergo the procedure, says a new large scale national study from University Hospitals Case Medical Center Seidman Cancer Center. Interestingly, the same analysis found that rates of routine mammography significantly increased following the ACA’s mandate for low or no cost screenings for Medicare recipients.

Released: 7-Dec-2015 7:00 PM EST
New Technology Developed at UH Seidman Cancer Center May Standardize Sickle Cell Disease Screenings for Infants in Developing Countries
University Hospitals Cleveland Medical Center

Researchers from Seidman Cancer Center at University Hospitals Case Medical Center and Case Western Reserve University School of Medicine presented new research findings this weekend at the Annual Meeting of the American Society of Hematology. In a poster presentation (Abstract #3379), Yunus Alapan, Umut Gurkan PhD and Jane Little, MD presented promising findings related to new technology aimed at facilitating early detection of sickle cell disease for infants in developing countries.

Released: 7-Dec-2015 10:05 AM EST
Neurosurgery Researchers Receive NIH Grants to Study Parkinson’s, Stroke, and Brain Cancer at Case Western Reserve University School of Medicine and University Hospitals Case Medical Center
University Hospitals Cleveland Medical Center

Researchers from the Department of Neurological Surgery at Case Western Reserve University School of Medicine and University Hospitals Case Medical Center recently received multi-year, multi-million dollar grants from the National Institutes of Health (NIH) for studies in Parkinson’s disease, stroke, and brain cancer.

4-Dec-2015 12:00 PM EST
University Hospitals Case Medical Center Names Daniel I. Simon, MD, as New President
University Hospitals Cleveland Medical Center

University Hospitals Case Medical Center has appointed Daniel I. Simon, MD, as the academic medical center’s new President effective Jan. 1, 2016. Dr. Simon will succeed Fred C. Rothstein, MD, who announced his retirement this summer after serving as President of UH Case Medical Center and one of the most influential leaders at the health system for the past 12 years. Dr. Simon is a nationally renowned leader in the field of cardiology. His dynamic leadership qualities and collegial style have enhanced the prominence of UH Harrington Heart & Vascular Institute, where he has served as Director since 2006 and as President since 2014.

Released: 23-Nov-2015 10:05 AM EST
A Tale of Two Cities: University Hospitals Brings Latest Technological Advancements in Cardiac Care to Cleveland’s East and West Sides
University Hospitals Cleveland Medical Center

University Hospitals physicians implanting Boston Scientific EMBLEM™ Subcutaneous Implantable Cardioverter-Defibrillator (S-ICD) System in patients who had survived a sudden cardiac arrest (SCA).

Released: 18-Nov-2015 2:05 PM EST
Nov. 19 Symposium Helps Celebrate Pioneering Biomedical Imaging Center’s 10th Anniversary
University Hospitals Cleveland Medical Center

Case Center for Imaging Research at Case Western Reserve University School of Medicine and University Hospitals Case Medical Center will celebrate its history and future with a symposium highlighting key technological advances from its faculty, a poster session of collaborative projects, and a key note address. The keynote speaker will be David Piwnica-Worms, MD, PhD, the Gerald Dewey Dodd, Jr., Endowed Distinguished Chair in Diagnostic Imaging, Division of Diagnostic Imaging at the University of Texas MD Anderson Cancer Center in Houston. He will speak about Tumor Heterogeneity and the Challenges of Molecular Imaging.

9-Nov-2015 11:00 AM EST
Management of High Blood Pressure Below a Commonly Recommended Blood Pressure Target Significantly Reduces Rates of Cardiovascular Events
University Hospitals Cleveland Medical Center

Jackson T. Wright Jr., MD, PhD, and researchers from University Hospitals Case Medical Center presented new results from the Systolic Blood Pressure Intervention Trial (SPRINT) showing that in patients at high risk for cardiovascular events, targeting a systolic blood pressure of less than 120 mm Hg resulted in lower rates of fatal and non-fatal major events or death compared to targeting systolic blood pressure to the usually recommended target of less than 140 mm Hg.

Released: 23-Oct-2015 12:05 PM EDT
New study at UH Rainbow Babies & Children’s Hospital characterizes pediatric ED visits attributed to contact with law enforcement
University Hospitals Cleveland Medical Center

In a first-of-its-kind study, researchers at University Hospitals Rainbow Babies & Children’s Hospital (UH Rainbow) found injuries related to legal interventions, or contact with law enforcement, involving male teenagers is not an uncommon occurrence in the United States. The study analyzed the Nationwide Emergency Department Sample (NEDS) between January 2008 and December 2010 and found 15,613 emergency department (ED) visits were attributed to injuries due to legal interventions involving children. Most visits occurred among males (82.8 percent) and teens between 15 to 17 years of age (83 percent). A blow or manhandling (terms used to classify legal interventions which do not involve a weapon) were the most common types of legal intervention (76.4 percent). Close to 68.5 percent of all ED visits occurred in areas with low annual income household levels.

7-Oct-2015 10:05 AM EDT
Study Finds Significant Decrease in Hospitalization of Older Nursing Home Residents with High Dose Influenza Vaccine
University Hospitals Cleveland Medical Center

Researchers found that flu immunizations with four times the strength of standard flu shots significantly reduced the risk of being hospitalized during the influenza season. The group that received the high dose vaccine had a 19.7 percent hospital admission rate versus 20.9 percent in admission for those who received the standard dose vaccine. The findings were presented as a late breaking research presentation on Oct. 10 at the Infectious Diseases Society of America meeting in San Diego.



close
2.63694